(UAN) CVR Partners - Overview
Stock: Ammonia, Urea, Ammonium, Nitrate, Fertilizer
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 13.59% |
| Yield on Cost 5y | 119.80% |
| Yield CAGR 5y | 26.53% |
| Payout Consistency | 58.2% |
| Payout Ratio | 99.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 33.4% |
| Relative Tail Risk | -19.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.27 |
| Alpha | 36.52 |
| Character TTM | |
|---|---|
| Beta | 0.453 |
| Beta Downside | 0.671 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.64% |
| CAGR/Max DD | 0.77 |
Description: UAN CVR Partners January 21, 2026
CVR Partners LP (NYSE: UAN) is a U.S.-based fertilizer producer that manufactures and sells ammonia and urea-ammonium nitrate (UAN) blends to agricultural and industrial customers. The company, incorporated in 2007 and headquartered in Sugar Land, Texas, operates under the GICS sub-industry “Fertilizers & Agricultural Chemicals.”
Key operational metrics that shape UAN’s outlook include: (1) annual production capacity of roughly 2.3 million metric tons of UAN, positioning it as one of the largest U.S. nitrogen fertilizer manufacturers; (2) EBITDA margins that have historically tracked natural-gas input costs, with a 2023-24 average margin of ~12 % when gas prices averaged $2.80 /MMBtu; and (3) demand exposure to U.S. corn and soybean acreage, which together account for over 70 % of domestic nitrogen fertilizer consumption, making planting-season weather and crop price expectations critical drivers of sales volume.
For a deeper quantitative view, ValueRay’s model offers a granular breakdown of UAN’s cash-flow sensitivities, which can help you assess how shifts in natural-gas pricing and crop-year demand might impact the stock.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 127.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 4.15 > 1.0 |
| NWC/Revenue: 29.42% < 20% (prev 23.03%; Δ 6.40% < -1%) |
| CFO/TA 0.18 > 3% & CFO 184.0m > Net Income 127.2m |
| Net Debt (428.7m) to EBITDA (271.1m): 1.58 < 3 |
| Current Ratio: 2.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (10.6m) vs 12m ago 0.0% < -2% |
| Gross Margin: 26.91% > 18% (prev 0.21%; Δ 2670 % > 0.5%) |
| Asset Turnover: 60.73% > 50% (prev 53.45%; Δ 7.28% > 0%) |
| Interest Coverage Ratio: 3.09 > 6 (EBITDA TTM 271.1m / Interest Expense TTM 60.9m) |
Beneish M -3.29
| DSRI: 1.14 (Receivables 47.8m/36.0m, Revenue 614.5m/527.4m) |
| GMI: 0.78 (GM 26.91% / 20.89%) |
| AQI: 0.59 (AQ_t 0.03 / AQ_t-1 0.05) |
| SGI: 1.17 (Revenue 614.5m / 527.4m) |
| TATA: -0.05 (NI 127.2m - CFO 184.0m) / TA 1.04b) |
| Beneish M-Score: -3.29 (Cap -4..+1) = AA |
What is the price of UAN shares?
Over the past week, the price has changed by -2.76%, over one month by -1.04%, over three months by +9.95% and over the past year by +44.10%.
Is UAN a buy, sell or hold?
What are the forecasts/targets for the UAN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9.5 | -90.8% |
| Analysts Target Price | 9.5 | -90.8% |
| ValueRay Target Price | 140.7 | 36% |
UAN Fundamental Data Overview February 05, 2026
P/S = 1.7673
P/B = 3.4098
P/EG = -1.3
Revenue TTM = 614.5m USD
EBIT TTM = 188.2m USD
EBITDA TTM = 271.1m USD
Long Term Debt = 548.3m USD (from longTermDebt, last quarter)
Short Term Debt = 4.96m USD (from shortTermDebt, last quarter)
Debt = 584.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 428.7m USD (from netDebt column, last quarter)
Enterprise Value = 1.46b USD (1.03b + Debt 584.9m - CCE 156.2m)
Interest Coverage Ratio = 3.09 (Ebit TTM 188.2m / Interest Expense TTM 60.9m)
EV/FCF = 10.57x (Enterprise Value 1.46b / FCF TTM 138.4m)
FCF Yield = 9.46% (FCF TTM 138.4m / Enterprise Value 1.46b)
FCF Margin = 22.53% (FCF TTM 138.4m / Revenue TTM 614.5m)
Net Margin = 20.70% (Net Income TTM 127.2m / Revenue TTM 614.5m)
Gross Margin = 26.91% ((Revenue TTM 614.5m - Cost of Revenue TTM 449.2m) / Revenue TTM)
Gross Margin QoQ = 21.48% (prev 32.41%)
Tobins Q-Ratio = 1.41 (Enterprise Value 1.46b / Total Assets 1.04b)
Interest Expense / Debt = 6.53% (Interest Expense 38.2m / Debt 584.9m)
Taxrate = 0.0% (0.0 / 43.1m)
NOPAT = 188.2m (EBIT 188.2m * (1 - 0.00%))
Current Ratio = 2.68 (Total Current Assets 288.6m / Total Current Liabilities 107.7m)
Debt / Equity = 1.84 (Debt 584.9m / totalStockholderEquity, last quarter 318.5m)
Debt / EBITDA = 1.58 (Net Debt 428.7m / EBITDA 271.1m)
Debt / FCF = 3.10 (Net Debt 428.7m / FCF TTM 138.4m)
Total Stockholder Equity = 307.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.57% (Net Income 127.2m / Total Assets 1.04b)
RoE = 41.38% (Net Income TTM 127.2m / Total Stockholder Equity 307.4m)
RoCE = 21.99% (EBIT 188.2m / Capital Employed (Equity 307.4m + L.T.Debt 548.3m))
RoIC = 22.00% (NOPAT 188.2m / Invested Capital 855.5m)
WACC = 7.21% (E(1.03b)/V(1.62b) * Re(7.59%) + D(584.9m)/V(1.62b) * Rd(6.53%) * (1-Tc(0.0)))
Discount Rate = 7.59% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 77.06% ; FCFF base≈119.4m ; Y1≈91.8m ; Y5≈57.5m
Fair Price DCF = 78.49 (EV 1.26b - Net Debt 428.7m = Equity 829.7m / Shares 10.6m; r=7.21% [WACC]; 5y FCF grow -27.44% → 2.90% )
EPS Correlation: -25.44 | EPS CAGR: -35.36% | SUE: 0.0 | # QB: 0
Revenue Correlation: -62.33 | Revenue CAGR: -3.77% | SUE: N/A | # QB: 0